Mike Lustgarten Tracks Biological Age and CVD Risk With His Second 2026 Blood Test
Researcher Mike Lustgarten analyzes his latest blood panel for biological age, cardiovascular risk, and diet correlations.
Summary
Mike Lustgarten, a longevity researcher, shares results from his second blood test of 2026, focusing on biological age via PhenoAge, cardiovascular disease risk using risk-weighted ApoB, and how specific dietary choices correlate with his biomarkers. Rather than relying on a single annual checkup, Lustgarten tracks frequent blood panels to detect trends and make precise dietary adjustments. Key metrics include inflammatory markers, lipid panels, kidney function, and epigenetic aging clocks. His approach demonstrates how self-quantification combined with diet tracking can help individuals identify what moves their health markers in the right direction. This video is part of an ongoing longitudinal self-experiment aimed at optimizing healthspan and slowing biological aging through data-driven lifestyle interventions.
Detailed Summary
Frequent blood testing is one of the most actionable strategies for monitoring biological aging and disease risk, and longevity researcher Mike Lustgarten continues to model this approach with his second blood panel of 2026. This video presents his latest results and explores what they reveal about his current trajectory toward — or away from — optimal healthspan.
The central focus is biological age as measured by PhenoAge, a validated algorithm that uses standard blood biomarkers to estimate how old your body is functioning relative to your chronological age. A lower biological age than chronological age is associated with reduced mortality risk and slower aging across multiple organ systems. Lustgarten's consistent tracking allows him to observe whether his interventions are genuinely moving this number in the right direction over time.
Cardiovascular disease risk receives significant attention through risk-weighted ApoB, a metric Lustgarten argues is more predictive than LDL cholesterol or non-HDL cholesterol alone. ApoB quantifies the number of atherogenic lipoprotein particles, making it a sharper signal for arterial disease risk. Monitoring this alongside traditional lipid markers gives a more complete picture of cardiovascular health.
A distinctive element of Lustgarten's methodology is correlating blood biomarker changes with specific dietary inputs tracked over time. By logging food intake meticulously and comparing it against sequential blood tests, he attempts to identify which foods drive improvements or deterioration in key markers. This diet-to-biomarker feedback loop is central to his "Conquer Aging or Die Trying" philosophy.
For longevity-focused individuals, the key implication is that single annual blood tests may miss important trends. Regular, strategic testing combined with detailed diet tracking offers a personalized, evidence-informed path to slowing biological aging. Caveats include the n=1 nature of self-experimentation and the need to interpret results within broader clinical context.
Key Findings
- PhenoAge biological age scoring from standard blood panels can reveal whether lifestyle changes are slowing aging.
- Risk-weighted ApoB may outperform LDL and non-HDL cholesterol as a cardiovascular disease predictor.
- Correlating diet logs with sequential blood tests helps identify which foods improve or worsen biomarkers.
- Frequent blood testing uncovers trends that a single annual panel would likely miss.
- Combining epigenetic clocks, metabolomics, and standard labs builds a comprehensive longevity monitoring stack.
Methodology
This is a personal longitudinal data video from Mike Lustgarten, PhD, a researcher at Tufts University known for rigorous self-quantification. The channel documents ongoing blood testing experiments with high frequency. No transcript was available; this summary is based on the video description and established context from the channel's body of work.
Study Limitations
This summary is based on the video description only, not the full spoken content, so specific numerical results and detailed dietary correlations discussed in the video are unavailable here. The data presented is from a single individual (n=1), limiting generalizability. Viewers should verify biomarker interpretations and testing protocols with a qualified healthcare provider before making clinical decisions.
Enjoyed this summary?
Get the latest longevity research delivered to your inbox every week.
Enter your email to subscribe: